Medicine and Dentistry
Disease Course
100%
Immunoglobulin
96%
Diagnosis
96%
Infection
72%
Cohort Study
72%
Guillain-Barré Syndrome
54%
Disease Severity
51%
Respiratory Failure
48%
Artificial Respiration
48%
Cohort Analysis
48%
Cell Count
48%
Placebo
48%
Diseases
48%
Weakness
40%
Odds Ratio
36%
Clinical Feature
27%
Clinical Finding
24%
Treatment Effect
24%
Cerebrospinal Fluid
24%
Electrophysiology
24%
Clinimetrics
24%
Polyradiculoneuropathy
24%
Disease Predisposition
24%
Overlap Syndrome
24%
Cohort Effect
24%
Symptom
18%
Muscle Weakness
16%
Leukocyte
16%
Electrodiagnosis
16%
Nerve Conduction Study
16%
Absence
16%
Cytomegalovirus
13%
Adverse Event
8%
Intention-to-Treat Analysis
8%
Epstein Barr Virus
6%
Hepatitis E Virus
6%
Immunology and Microbiology
Intravenous Immunoglobulin
96%
Guillain-Barré Syndrome
56%
Protein Cerebrospinal Fluid Level
48%
Limb
48%
Cytomegalovirus
48%
Cell Count
32%
Hepatitis E Virus
24%
Epstein Barr Virus
24%
Nerve Conduction
16%
Leukocyte Count
16%
Campylobacter Jejuni
12%
Coinfection
12%
Mycoplasma pneumoniae
12%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
96%
Infection
48%
Immunoglobulin
48%
Placebo
48%
Guillain Barre Syndrome
14%
Cytomegalovirus
13%
Adverse Event
8%
Hepatitis E Virus
6%
Symptom
6%
Epstein-Barr Virus
6%